HTT and Huntington disease: Single bilateral injections of AAV-encased anti-HTT shRNA were delivered into the striatum of HD transgenic mice (N171-82Q), leading to significant reductions in both mutant HTT mRNA levels and in the formation of HTT inclusions (which are a pathognomic feature of HD) [20].